Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Melanoma × Immunotherapy × Clear all

Phase

Status

Sponsor Class

OTHER 13 INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Pancreatic Cancer Liver Metastases 1 Neoplasms 1 Melanoma 1 Colorectal Neoplasms 1

Interventions

Interleukin-2 4 Nivolumab 3 Melphalan 3 pembrolizumab 2 tremelimumab 1 tislelizumab 1 fludarabine 1 encorafenib 1 binimetinib 1 apatinib 1 Tramadol 1 Surgical Procedures, Operative 1 Metastasectomy 1 Ipilimumab 1 Immunotherapy 1 Ibuprofen 1 FMT protocol 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04242329 2024-01-26

SUMMIST

Vastra Gotaland Region

Phase 2 Withdrawn

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡